# FDA Inspection 923130 - Vitalant - April 17, 2015

Source: https://www.keypedia.com/records/fda_inspections/vitalant/f2493f74-4dd1-463a-8860-a6e281fcccb4
Source feed: FDA_Inspections

> FDA Inspection 923130 for Vitalant on April 17, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 923130
- Company Name: Vitalant
- Inspection Date: 2015-04-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1099221 - 2019-08-06](https://www.keypedia.com/records/fda_inspections/vitalant/7fa85297-b053-4365-b356-6bb034797682)
- [FDA Inspection 996034 - 2016-12-05](https://www.keypedia.com/records/fda_inspections/vitalant/91c551cc-1b22-4431-ad43-a4f58251609f)
- [FDA Inspection 851645 - 2013-10-09](https://www.keypedia.com/records/fda_inspections/vitalant/515b1313-c7d3-4528-bb32-ad54128f237d)
- [FDA Inspection 763446 - 2012-01-17](https://www.keypedia.com/records/fda_inspections/vitalant/4dce0c73-8146-4f39-8871-84780bcae65c)
- [FDA Inspection 664283 - 2010-05-27](https://www.keypedia.com/records/fda_inspections/vitalant/003cd69c-7510-4ceb-8cad-72dd1aa7f554)

Company: https://www.keypedia.com/companies/vitalant/8a92985c-d8a6-441a-92af-a9177275f7b4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d